The U.S. Food and Drug Administration (FDA) has published updates to The Seafood List—FDA’s Guide to Determine Acceptable Seafood Names: Guidance for Industry.
On August 24, 2023, the U.S. Food and Drug Administration (FDA) signed a Regulatory Partnership Arrangement (RPA) with Ecuador’s Vice Ministry of Aquaculture and Fisheries (VMAF) to strengthen the food safety of Ecuadorian shrimp intended for sale in the U.S. market.
The U.S. Food and Drug Administration (FDA) has provided and update on the agency’s activities to better understand per- and polyfluoroalkyl substances (PFAS) in the food supply, including recent testing results, progress on seafood-related work, and advances in testing methods.
Researchers at the University of Texas Southwestern Medical Center have discovered how foodborne pathogen Vibrio parahaemolyticus infects people after eating raw or undercooked shellfish. The findings could lead to new ways to treat illness caused by the enteric bacteria.
The U.S. Food and Drug Administration (FDA) has released a report, titled, Activities for the Safety of Imported Seafood. The document shares the steps that FDA is taking to ensure that seafood imported to the U.S. meets food safety requirements and the standards of domestically produced seafood.
The Joint FAO/WHO Expert Meeting in Microbial Risk Assessment (JERMA) convened in response to a Codex Alimentarius Committee request to develop microbiological risk assessment models for Listeria monocytogenes, and to provide recommendations to inform possible future revisions to Codex guidelines on hygienic controls for L. monocytogenes.
As part of the Closer to Zero Action Plan, the U.S. Food and Drug Administration has asked the National Academies of Sciences, Engineering, and Medicine to conduct an independent study to assess young children’s exposure to mercury from consuming seafood.
The U.S. Food and Drug Administration (FDA) has launched the third phase of the Artificial Intelligence (AI) Imported Seafood Pilot program, which uses AI and machine learning to strengthen the screening process for seafood imports entering the U.S.
A recent study has expanded upon the available knowledge about Arcobacter, an emerging foodborne pathogen that causes human illness, revealing findings related to Arcobacter’s food sources, virulence and biofilm formation traits, and genetic characterization.
Ciguatera toxin, which does not break down during cooking, can cause severe foodborne illness in humans who consume contaminated reef fish that feed on toxic microalgae. Climate change is altering algal and seaweed growth patterns, which may impact the rate of ciguatoxin accumulation by these fish species.
